Fluid administration in septic shock

Sepsis

Volumn 4, Issue 2, 2001, Pages 111-124

  Grocott, M P W ^a   Mythen, M G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BICARBONATE; CALCIUM ION; CHLORIDE ION; DEXTRAN; GELATIN; GELATIN SUCCINATE; GLUCOSE; HETASTARCH; LACTIC ACID; POLYGELINE; POTASSIUM ION; SODIUM CHLORIDE; SODIUM ION;

ANAPHYLAXIS; COLLOID; FLUID THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; OSMOLARITY; PATHOPHYSIOLOGY; PH; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0035025253     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011450703625     Document Type: Review

References (86)

1. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine
2. Consensus conferance definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation
3. Pathogenetic mechanisms of septic shock
4. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans
5. Persistent preload defect in severe sepsis despite fluid leading: A longitudinal echocardiographic study in patients with septic shock
6. Physiologic management of septicemic shock in man
7. The hemodynamic derangements in sepsis: Implications for treatment strategies
8. The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis
9. Microcirculatory oxygenation and shunting in sepsis and shock
10. Fluid management in Intensive Care - The avoidance of hypovolaemia
11. The new generation gelatins. A review of their history manufacture and properties
12. Pharmacology and physiology of colloids
13. Synthetic plasma volume expanders - Their pharmacology, safety and clinical efficacy
14. An international view of hydroxyethyl starches
15. Plasma volume changes after infusion of various plasma expanders
16. In vitro colloid osmotic pressure of commonly used plasma expanders and substitutes: A study of the diffusibility of colloid molecules
17. Reduced quality of clot formation with gelatin-based plasma substitutes
18. Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: An international multicentre study
19. Coagulation disorders caused by hydroxyethyl starch
20. Influence of intravascular molecular weight of hydroxyethyl starch on platelets
21. Effects of hetastarch and albumin on coagulation in patients with septic shock
22. Effects of pentastarch and albumin infusion on cardio respiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion
23. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery
24. Peri-operative tolerance to large-dose 6% HES 200/0.5 in major urological procedures compared with 5% human albumin
25. Effect of crystalloid and colloid solutions on blood rheology in sepsis
26. A comparison of the effects of artificial plasma substitutes, albumin and saline solutions on in vitro apparent blood viscocoty
27. Organ blood supply and oxygenation during limited isovolemic hemodilution with 6% HES 200/0.62 and 6% Dextran 70
28. Rheologic effects of plasma substitutes used for preoperative hemodilution
29. In vivo effects of plasma substitutes on the rheologic properties of blood
30. Rheological properties of commonly used plasma substitutes during preoperative normovolaemic acute haemodilution
31. Incidence and severity of anaphylactoid reactions to colloid volume substitutes
32. Anaphylactoid reactions to colloid plasma substitutes: Incidence, risk factors, mechanisms. A French multicenter prospective study
33. Safety of dextran in relation to other colloids-Ten years experience with hapten inhibition
34. Mad colloid disease?
35. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury
36. A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis
37. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep
38. Pentafraction reduces the lung lymph response after endotoxin administration in the ovine model
39. Medium molecular weight pentastarch reduces reperfusion injury by decreasing capillary leak in an animal model of spinal cord ischemia
40. Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch
41. Effects of pentafraction administration on microvascular permeability alterations induced by graded thermal injury
42. Global cerebral ischemia: Effects of pentastarch after reperfusion
43. Effects of hypertonic saline and dextran 70 resuscitation on microvascular permeability after burn
44. Effects on capillary fluid permeability and fluid exchange of albumin, dextran, gelatin, and hydroxyethyl starch in cat skeletal muscle
45. Plugging the leaks? New insights into synthetic colloids
46. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation
47. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation: An in vitro study
48. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: Restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels
49. Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients
50. Attenuation of postischemic microvascular disturbances in striated muscle by hyperosmolar saline dextran
51. Human neutrophil activation and increased adhesion by various resuscitation fluids
52. Crystalloid versus colloid fluid resuscitation: A meta-analysis of mortality
53. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomised trials
54. Crystalloids vs. colloids in fluid resuscitation: A systematic review
55. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers
56. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers
57. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery
58. Randomized controlled that of balanced versus sodium chloride based intravenous solutions in the elderly surgical patient
59. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: A randomized phase III clinical trial. Hextend Study Group
60. Red blood cell substitutes: Fluorocarbon emulsions and haemoglobin solutions
61. Hemoglobin solutions: An "all-in-one" therapeutic strategy in sepsis?
62. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis
63. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group
64. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine
65. Plasma expansion in surgical patients with high central venous pressure (CVP): The relationship of blood volume to hematocrit, CVP, pulmonary wedge pressure, and cardiorespiratory changes
66. Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients
67. Clinical assessment of hemodynamic values in two surgical intensive care units. Effects on therapy
68. Clinical use of respiratory changes in arterial pulse pressure to monitor the hemodynamic effects of PEEP
69. Systolic pressure variation as a guide to fluid therapy in patients with sepsis-induced hypotension
70. Relation between repiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure
71. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients
72. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients
73. Reducing the risk of major elective surgery: Randomised controlled trial of preoperative optimisation of oxygen delivery
74. Perioperative plasma volume expansion reduces the incidence of gut gut mucosal hypoperfusion during cardiac surgery
75. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: Randomised controlled trial
76. Elevation of cardiac output and oxygen delivery improves outcome in septic shock
77. Elevation of systemic oxygen delivery in the treatment of critically ill patients
78. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group
79. Understanding gastrointestinal perfusion in critical care: So near, and yet so far
80. Gastric Mucoasal pH as a prognostic index of mortality in critically ill patients
81. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure
82. Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis
83. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients
84. Sublingual capnometry: A new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock
85. Bladder epithelial oxygen tension as a marker of organ perfusion
86. Orthogonal polarization spectral imaging: A new method for study of the microcirculation